Published in Bioorg Med Chem Lett on October 20, 1998
Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR. J Clin Invest (2003) 6.04
The Concise Guide to PHARMACOLOGY 2013/14: enzymes. Br J Pharmacol (2013) 5.57
The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity. EMBO J (2006) 3.57
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases. Proc Natl Acad Sci U S A (2007) 3.21
PDGF signalling controls age-dependent proliferation in pancreatic β-cells. Nature (2011) 2.53
Probing the probes: fitness factors for small molecule tools. Chem Biol (2010) 2.08
Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF. J Clin Invest (2002) 1.95
ERK1/2 is activated in non-small-cell lung cancer and associated with advanced tumours. Br J Cancer (2004) 1.88
Hypoxic inducible factor 1alpha, extracellular signal-regulated kinase, and p53 are regulated by distinct threshold concentrations of nitric oxide. Proc Natl Acad Sci U S A (2004) 1.87
FATP1 is an insulin-sensitive fatty acid transporter involved in diet-induced obesity. Mol Cell Biol (2006) 1.70
A noncanonical Frizzled2 pathway regulates epithelial-mesenchymal transition and metastasis. Cell (2014) 1.44
Elevated insulin-like growth factor 1 receptor signaling induces antiestrogen resistance through the MAPK/ERK and PI3K/Akt signaling routes. Breast Cancer Res (2011) 1.37
Core erythropoietin receptor signals for late erythroblast development. Blood (2005) 1.26
Enterohemorrhagic Escherichia coli infection induces interleukin-8 production via activation of mitogen-activated protein kinases and the transcription factors NF-kappaB and AP-1 in T84 cells. Infect Immun (2002) 1.24
PI3K/Akt-sensitive MEK-independent compensatory circuit of ERK activation in ER-positive PI3K-mutant T47D breast cancer cells. Cell Signal (2010) 1.18
Noncatalytic function of ERK1/2 can promote Raf/MEK/ERK-mediated growth arrest signaling. J Biol Chem (2009) 1.18
SP600125 suppresses Cdk1 and induces endoreplication directly from G2 phase, independent of JNK inhibition. Oncogene (2010) 1.14
A computational framework for the topological analysis and targeted disruption of signal transduction networks. Biophys J (2006) 1.12
Chemical reprogramming of Caenorhabditis elegans germ cell fate. Nat Chem Biol (2009) 1.11
Data-driven modeling reconciles kinetics of ERK phosphorylation, localization, and activity states. Mol Syst Biol (2014) 1.09
Site-specific activation of AKT protects cells from death induced by glucose deprivation. Oncogene (2013) 1.08
Activation of Erk by sonic hedgehog independent of canonical hedgehog signalling. Int J Biochem Cell Biol (2010) 1.07
High-throughput ectopic expression screen for tamoxifen resistance identifies an atypical kinase that blocks autophagy. Proc Natl Acad Sci U S A (2011) 1.07
CD28 and the tyrosine kinase lck stimulate mitogen-activated protein kinase activity in T cells via inhibition of the small G protein Rap1. Mol Cell Biol (2000) 1.06
Higher polymerase activity of a human influenza virus enhances activation of the hemagglutinin-induced Raf/MEK/ERK signal cascade. Virol J (2007) 1.05
Oncogenic Kras promotes chemotherapy-induced growth factor shedding via ADAM17. Cancer Res (2010) 1.05
GDNF family ligands trigger indirect neuroprotective signaling in retinal glial cells. Mol Cell Biol (2006) 1.04
Phrenic long-term facilitation after acute intermittent hypoxia requires spinal ERK activation but not TrkB synthesis. J Appl Physiol (1985) (2012) 1.02
Apoptosis induction by oxidized glycated LDL in human retinal capillary pericytes is independent of activation of MAPK signaling pathways. Mol Vis (2009) 1.01
MAPK/ERK1/2 and PI3-kinase signalling pathways are required for vitreous-induced lens fibre cell differentiation. Exp Eye Res (2008) 1.00
The small molecule Mek1/2 inhibitor U0126 disrupts the chordamesoderm to notochord transition in zebrafish. BMC Dev Biol (2008) 0.97
Alternative splicing of human papillomavirus type-16 E6/E6* early mRNA is coupled to EGF signaling via Erk1/2 activation. Proc Natl Acad Sci U S A (2010) 0.96
Identification of an In Vivo MEK/WOX1 Complex as a Master Switch for Apoptosis in T Cell Leukemia. Genes Cancer (2011) 0.96
The antinociceptive effects of nicotinic receptors α7-positive allosteric modulators in murine acute and tonic pain models. J Pharmacol Exp Ther (2012) 0.95
Elevated P75NTR expression causes death of engrailed-deficient midbrain dopaminergic neurons by Erk1/2 suppression. Neural Dev (2009) 0.94
Multiple phosphorylation events control mitotic degradation of the muscle transcription factor Myf5. BMC Biochem (2005) 0.91
Interaction between uric acid and HMGB1 translocation and release from endothelial cells. Am J Physiol Renal Physiol (2011) 0.90
Glial cell line-derived neurotrophic factor (GDNF) induces neuritogenesis in the cochlear spiral ganglion via neural cell adhesion molecule (NCAM). Mol Cell Neurosci (2012) 0.90
ERK1/2 activation induced by inflammatory cytokines compromises effective host tissue integration of engineered cartilage. Tissue Eng Part A (2009) 0.87
Erk1/2 inhibit synaptic vesicle exocytosis through L-type calcium channels. J Neurosci (2011) 0.87
Cardioprotection by mild hypothermia during ischemia involves preservation of ERK activity. Basic Res Cardiol (2011) 0.87
Inhibitors of p38 and ERK1/2 MAPkinase and hydrogen sulphide block constitutive and IL-1β-induced IL-6 and IL-8 expression in the human chondrocyte cell line C-28/I2. Rheumatol Int (2010) 0.87
Mitosis-meiosis and sperm-oocyte fate decisions are separable regulatory events. Proc Natl Acad Sci U S A (2013) 0.86
Glycodelin-A protein interacts with Siglec-6 protein to suppress trophoblast invasiveness by down-regulating extracellular signal-regulated kinase (ERK)/c-Jun signaling pathway. J Biol Chem (2011) 0.86
Mediation of basic fibroblast growth factor-induced lactotropic cell proliferation by Src-Ras-mitogen-activated protein kinase p44/42 signaling. Endocrinology (2005) 0.84
Phosphorylation of the Drosophila melanogaster RNA-binding protein HOW by MAPK/ERK enhances its dimerization and activity. PLoS Genet (2012) 0.84
Protection of cells in physiological oxygen tensions against DNA damage-induced apoptosis. J Biol Chem (2010) 0.83
Inhibition of p38 MAPK diminishes doxorubicin-induced drug resistance associated with P-glycoprotein in human leukemia K562 cells. Med Sci Monit (2012) 0.83
Cox-2-derived PGE2 induces Id1-dependent radiation resistance and self-renewal in experimental glioblastoma. Neuro Oncol (2016) 0.82
Dual suppression of the cyclin-dependent kinase inhibitors CDKN2C and CDKN1A in human melanoma. J Natl Cancer Inst (2012) 0.82
Role of protein kinase C-Ras-MAPK p44/42 in ethanol and transforming growth factor-beta3-induced basic fibroblast growth factor release from folliculostellate cells. J Pharmacol Exp Ther (2005) 0.81
7-Ketocholesterol-induced inflammation signals mostly through the TLR4 receptor both in vitro and in vivo. PLoS One (2014) 0.81
Anti-inflammatory mechanism of polyunsaturated fatty acids in Helicobacter pylori-infected gastric epithelial cells. Mediators Inflamm (2014) 0.81
Function of phosphoenolpyruvate carboxykinase in mammary gland epithelial cells. J Lipid Res (2011) 0.81
Tricyclic Antidepressant Amitriptyline-induced Glial Cell Line-derived Neurotrophic Factor Production Involves Pertussis Toxin-sensitive Gαi/o Activation in Astroglial Cells. J Biol Chem (2015) 0.80
Activation of JNK triggers release of Brd4 from mitotic chromosomes and mediates protection from drug-induced mitotic stress. PLoS One (2012) 0.80
Extracellular signal-regulated kinases 1/2 as regulators of cardiac hypertrophy. Front Pharmacol (2015) 0.80
Significance of increased expression of decoy receptor 3 in chronic liver disease. Dig Liver Dis (2009) 0.80
Potentiation of carbachol-induced detrusor smooth muscle contractions by beta-adrenoceptor activation. Eur J Pharmacol (2009) 0.80
Opioid-induced mitogen-activated protein kinase signaling in rat enteric neurons following chronic morphine treatment. PLoS One (2014) 0.79
Mitogen-activated protein kinase (MAPK/ERK) regulates adenomatous polyposis coli during growth-factor-induced cell extension. J Cell Sci (2012) 0.79
Fibroblast growth factor 2 causes G2/M cell cycle arrest in ras-driven tumor cells through a Src-dependent pathway. PLoS One (2013) 0.79
Effect of phorbol 12-myristate 13-acetate activated signaling pathways on 1α, 25 dihydroxyvitamin D3 regulated human 25-hydroxyvitamin D3 24-hydroxylase gene expression in differentiated Caco-2 cells. J Cell Biochem (2012) 0.79
Caenorhabditis elegans: A Model System for Anti-Cancer Drug Discovery and Therapeutic Target Identification. Biomol Ther (Seoul) (2014) 0.78
Platycodin D induces apoptosis and triggers ERK- and JNK-mediated autophagy in human hepatocellular carcinoma BEL-7402 cells. Acta Pharmacol Sin (2015) 0.78
Akt mediated phosphorylation of LARP6; critical step in biosynthesis of type I collagen. Sci Rep (2016) 0.78
ERK activation is required for CCK-mediated pancreatic adaptive growth in mice. Am J Physiol Gastrointest Liver Physiol (2014) 0.78
Effects of intravitreal insulin and insulin signaling cascade inhibitors on emmetropization in the chick. Mol Vis (2012) 0.77
Extracellular signal-regulated kinase phosphorylation in forebrain neurones contributes to osmoregulatory mechanisms. J Physiol (2014) 0.77
U0126 protects cells against oxidative stress independent of its function as a MEK inhibitor. ACS Chem Neurosci (2015) 0.77
Activation of Transient Receptor Potential Vanilloid 4 Promotes the Proliferation of Stem Cells in the Adult Hippocampal Dentate Gyrus. Mol Neurobiol (2016) 0.76
Experimental and computational analysis of a large protein network that controls fat storage reveals the design principles of a signaling network. PLoS Comput Biol (2015) 0.76
Quantification of a Pharmacodynamic ERK End Point in Melanoma Cell Lysates: Toward Personalized Precision Medicine. ACS Med Chem Lett (2014) 0.76
CCL3 promotes angiogenesis by dysregulation of miR-374b/ VEGF-A axis in human osteosarcoma cells. Oncotarget (2016) 0.76
Insulin-like growth factors are essential to prevent anoikis in oestrogen-responsive breast cancer cells: importance of the type I IGF receptor and PI3-kinase/Akt pathway. Mol Cancer (2016) 0.76
Geniposide, the component of the Chinese herbal formula Tongluojiunao, protects amyloid-β peptide (1-42-mediated death of hippocampal neurons via the non-classical estrogen signaling pathway. Neural Regen Res (2014) 0.76
Mutations associated with retinopathies alter mitogen-activated protein kinase-induced phosphorylation of neural retina leucine-zipper. Mol Vis (2007) 0.76
The DIONESUS algorithm provides scalable and accurate reconstruction of dynamic phosphoproteomic networks to reveal new drug targets. Integr Biol (Camb) (2015) 0.75
Concomitant inhibition of receptor tyrosine kinases and downstream AKT synergistically inhibited growth of KRAS/BRAF mutant colorectal cancer cells. Oncotarget (2017) 0.75
DNA synthesis during endomitosis is stimulated by insulin via the PI3K/Akt and TOR signaling pathways in the silk gland cells of Bombyx mori. Int J Mol Sci (2015) 0.75
IL-32γ delays spontaneous apoptosis of human neutrophils through MCL-1, regulated primarily by the p38 MAPK pathway. PLoS One (2014) 0.75
Activation of the Extracellular Signal-Regulated Kinase Signaling Is Critical for Human Umbilical Cord Mesenchymal Stem Cell Osteogenic Differentiation. Biomed Res Int (2016) 0.75
Direct interaction of avermectin with epidermal growth factor receptor mediates the penetration resistance in Drosophila larvae. Open Biol (2016) 0.75
The S100P/RAGE signaling pathway regulates expression of microRNA-21 in colon cancer cells. FEBS Lett (2015) 0.75
Visualization of Compartmentalized Kinase Activity Dynamics Using Adaptable BimKARs. Chem Biol (2015) 0.75
The inhibitory effect of Gβγ and Gβ isoform specificity on ENaC activity. Am J Physiol Renal Physiol (2013) 0.75
Phosphoproteomics of Primary Cells Reveals Druggable Kinase Signatures in Ovarian Cancer. Cell Rep (2017) 0.75
Blockage of neddylation modification stimulates tumor sphere formation in vitro and stem cell differentiation and wound healing in vivo. Proc Natl Acad Sci U S A (2016) 0.75
Biphasic Regulation of p38 MAPK by Serotonin Contributes to the Efficacy of Stimulus Protocols That Induce Long-Term Synaptic Facilitation. eNeuro (2017) 0.75
Sustained Contraction in Vascular Smooth Muscle by Activation of L-type Ca(2+) Channels Does Not Involve Ca(2+) Sensitization or Caldesmon. Front Pharmacol (2016) 0.75
Activation of Sphingosine 1-Phosphate Receptor 1 Enhances Hippocampus Neurogenesis in a Rat Model of Traumatic Brain Injury: An Involvement of MEK/Erk Signaling Pathway. Neural Plast (2016) 0.75
Triptolide-assisted phosphorylation of p53 suppresses inflammation-induced NF-κB survival pathways in cancer cells. Mol Cell Biol (2017) 0.75
The expression of keratin 6 is regulated by the activation of the ERK1/2 pathway in arsenite transformed human urothelial cells. Toxicol Appl Pharmacol (2017) 0.75
Proteomic Expression Changes in Large Cerebral Arteries After Experimental Subarachnoid Hemorrhage in Rat Are Regulated by the MEK-ERK1/2 Pathway. J Mol Neurosci (2017) 0.75
A system for rapid DNA sequencing with fluorescent chain-terminating dideoxynucleotides. Science (1987) 14.05
Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem (1998) 13.93
Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell (1996) 7.46
The functional relationship of the interleukins. J Exp Med (1980) 5.62
Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev (1993) 4.69
Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell (1997) 4.69
The MAPK cascade is required for mammalian associative learning. Nat Neurosci (1998) 4.61
SECTION OF THE SYMPATHETIC NERVES OF THE DISTAL PART OF THE COLON AND THE RECTUM IN THE TREATMENT OF HIRSCHSPRUNG'S DISEASE AND CERTAIN TYPES OF CONSTIPATION. Ann Surg (1930) 3.72
Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins. Science (1999) 3.22
Replication of a plasmid containing two origins of bacteriophage. J Mol Biol (1981) 3.21
Production and characterization of monoclonal antibodies to human interleukin 2: strategy and tactics. J Immunol (1983) 3.10
Functional analysis of influenza-specific helper T cell clones in vivo. T cells specific for internal viral proteins provide cognate help for B cell responses to hemagglutinin. J Exp Med (1986) 2.89
Genetic Bit Analysis: a solid phase method for typing single nucleotide polymorphisms. Nucleic Acids Res (1994) 2.79
Diverticula of the Small Bowel. Ann Surg (1934) 2.44
Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta. Genes Dev (1999) 2.37
Presenilin-1 and -2 are molecular targets for gamma-secretase inhibitors. J Biol Chem (2000) 2.33
Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS family. J Biol Chem (1999) 2.33
Site-specific cleavage of single-stranded DNA by a Hemophilus restriction endonuclease. Proc Natl Acad Sci U S A (1975) 2.32
Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med (1992) 2.31
Identification of angiotensin II receptor subtypes. Biochem Biophys Res Commun (1989) 2.23
Inhibition of mitogen-activated protein kinase kinase blocks T cell proliferation but does not induce or prevent anergy. J Immunol (1998) 2.18
Origin and direction of synthesis of bacteriophage fl DNA. Proc Natl Acad Sci U S A (1976) 2.15
The functional origin of bacteriophage f1 DNA replication. Its signals and domains. J Mol Biol (1984) 2.13
A necessity for MAP kinase activation in mammalian spatial learning. Learn Mem (1999) 2.04
Clinical teaching in physical therapy: student and teacher perceptions. Phys Ther (1990) 2.01
Lymphocyte activating factor promotes T-cell growth factor production by cloned murine lymphoma cells. Nature (1980) 1.99
Cleavage of bacteriophage fl DNA by the restriction enzyme of Escherichia coli B. Proc Natl Acad Sci U S A (1972) 1.90
Physical map of defective interfering particles of bacteriophage f1. J Mol Biol (1977) 1.87
Complement and C3-proactivator levels in children with protein-calorie malnutrition and effect of dietary treatment. Lancet (1973) 1.79
Cloning and nucleotide sequence of the ispA gene responsible for farnesyl diphosphate synthase activity in Escherichia coli. J Biochem (1990) 1.73
TUBERCULOSIS OF THE THYROID GLAND. Ann Surg (1932) 1.72
Initiation of minus-strand RNA synthesis by the brome mosaicvirus RNA-dependent RNA polymerase: use of oligoribonucleotide primers. J Virol (1996) 1.70
Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase. Proc Natl Acad Sci U S A (1994) 1.69
Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine. Mol Pharmacol (2000) 1.64
Characterization of G-protein alpha subunits in the Gq class: expression in murine tissues and in stromal and hematopoietic cell lines. Proc Natl Acad Sci U S A (1991) 1.63
Initiation and termination of phage f1 plus-strand synthesis. Proc Natl Acad Sci U S A (1982) 1.60
LYMPHO-SARCOMA OF THE SMALL INTESTINES. Ann Surg (1924) 1.60
Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent. J Pharmacol Exp Ther (1990) 1.60
Cleavage map of bacteriophage f1: location of the Escherichia coli B-specific modification sites. J Mol Biol (1975) 1.60
Molecular analysis of non-syndromic preaxial polydactyly: preaxial polydactyly type-IV and preaxial polydactyly type-I. Clin Genet (2005) 1.58
Different complexes are formed on the 3' end of histone mRNA with nuclear and polyribosomal proteins. Nucleic Acids Res (1991) 1.58
Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent. J Pharmacol Exp Ther (1990) 1.57
Rapid inhibition of interleukin-6 signaling and Stat3 activation mediated by mitogen-activated protein kinases. Proc Natl Acad Sci U S A (1998) 1.56
MULTIPLE CARCINOMATA OF THE LARGE INTESTINE. Ann Surg (1930) 1.54
Endonuclease R-EcoRII restriction of bacteriophage f1 DNA in vitro: ordering of genes V and VII, location of an RNA promotor for gene VIII. J Virol (1975) 1.54
Point mutations in the stem-loop at the 3' end of mouse histone mRNA reduce expression by reducing the efficiency of 3' end formation. Mol Cell Biol (1994) 1.53
TEMPORARY BILATERAL ABDUCTOR PARALYSIS WITHOUT NERVE INJURY AFTER THYROIDECTOMY. Ann Surg (1929) 1.53
Mechanisms of defective delayed cutaneous hypersensitivity in children with protein-calorie malnutrition. Lancet (1973) 1.52
Dissociation of vasoconstrictor and platelet aggregatory activities of thromboxane by carbocyclic thromboxane A2, a stable analog of thromboxane A2. Proc Natl Acad Sci U S A (1980) 1.52
Nonpeptide angiotensin II receptor antagonists: the discovery of a series of N-(biphenylylmethyl)imidazoles as potent, orally active antihypertensives. J Med Chem (1991) 1.50
Histological and ultrastructural features of atherosclerosis in progeria. Cardiovasc Pathol (2000) 1.48
The immunosuppressive metabolite of leflunomide is a potent inhibitor of human dihydroorotate dehydrogenase. Biochemistry (1996) 1.48
Synthesis and biological properties of pinane-thromboxane A2, a selective inhibitor of coronary artery constriction, platelet aggregation, and thromboxane formation. Proc Natl Acad Sci U S A (1979) 1.47
Potent antisense oligonucleotides to the human multidrug resistance-1 mRNA are rationally selected by mapping RNA-accessible sites with oligonucleotide libraries. Nucleic Acids Res (1996) 1.47
Nonpeptide angiotensin II receptor antagonists. VIII. Characterization of functional antagonism displayed by DuP 753, an orally active antihypertensive agent. J Pharmacol Exp Ther (1990) 1.46
A cell division inhibitor SulA of Escherichia coli directly interacts with FtsZ through GTP hydrolysis. Biochem Biophys Res Commun (1995) 1.46
7,8-Dihydro-8-oxoadenine as a replacement for cytosine in the third strand of triple helices. Triplex formation without hypochromicity. Biochemistry (1993) 1.43
Inhibition of MAP kinase kinase prevents cytokine and prostaglandin E2 production in lipopolysaccharide-stimulated monocytes. J Immunol (1998) 1.43
THE VALUE OF CECOSTOMY AS A COMPLEMENTARY AND DECOMPRESSIVE OPERATION. Ann Surg (1939) 1.43
Nutrition as a theme for the study and practice of medicine. Nutr Rev (1979) 1.43
Origin of DNA replication of bacteriophage f1 as the signal for termination. Proc Natl Acad Sci U S A (1980) 1.42
Replication origin of bacteriophage f1. Two signals required for its function. J Mol Biol (1982) 1.41
Two new potent neurotransmitter release enhancers, 10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone and 10,10-bis(2-fluoro-4-pyridinylmethyl)-9(10H)-anthracenone: comparison to linopirdine. J Pharmacol Exp Ther (1998) 1.39
Multiregulatory element of filamentous bacteriophages. Microbiol Rev (1985) 1.39
POST-OPERATIVE PAROTIDITIS: TREATMENT WITHOUT AND WITH RADIUM. Ann Surg (1930) 1.38
Dependence of Dbl and Dbs transformation on MEK and NF-kappaB activation. Mol Cell Biol (1999) 1.38
DNA replication of bacteriophage f1 in vivo. Cold Spring Harb Symp Quant Biol (1979) 1.38
Apixaban, an oral, direct and highly selective factor Xa inhibitor: in vitro, antithrombotic and antihemostatic studies. J Thromb Haemost (2008) 1.38
Minimal templates directing accurate initiation of subgenomic RNA synthesis in vitro by the brome mosaic virus RNA-dependent RNA polymerase. RNA (1997) 1.35
Human mdm2 mediates multiple mono-ubiquitination of p53 by a mechanism requiring enzyme isomerization. J Biol Chem (2001) 1.35
Interaction between gene II protein and the DNA replication origin of bacteriophage f1. J Mol Biol (1986) 1.35
Effect of deoxyribonucleic acid length on the adenosine triphosphatase activity of Escherichia coli restriction endonuclease B. J Biol Chem (1974) 1.33
Indoleamine 2,3-dioxygenase, an emerging target for anti-cancer therapy. Curr Cancer Drug Targets (2009) 1.32
Secretory and serum IgA in children with protein-calorie malnutrition. Pediatrics (1975) 1.31
Biodistribution and metabolism of internally 3H-labeled oligonucleotides. I. Comparison of a phosphodiester and a phosphorothioate. Mol Pharmacol (1994) 1.30